Halifax’s Winter 2021 Lab2Market Cohort by the Numbers

Halifax’s Winter 2021 Lab2Market cohort has had a busy 16-weeks.

22 research teams from 10 universities were invited to join the program to validate their ideas through customer discovery with the purpose of finding business or commercial value. Congratulations to the graduates, we look forward to following your success as you move on to incubators and accelerators (like Ready2Launch), complete research initiatives and further develop your company. Learn more about the Halifax’s Winter 2021 Lab2Market cohort by the numbers:

About Lab2Market

Lab2Market supports researchers who foresee impact and potential commercial value in their deep tech research, by providing opportunities and exposure to help commercialize their intellectual property. The program is developed and led by Dalhousie University, Memorial University, and Ryerson University, and leverages the national I-INC network. Learn more at Lab2Market

Sign up for our newsletter and stay up to date with Dal Innovates.

About Dalhousie University

Dalhousie is the only East Coast member of Canada’s U15, the country’s leading group of research-intensive universities. With more than 250 million dollars in annual research funding, we are Atlantic Canada’s engine of discovery and innovation. Anchored in Halifax, Nova Scotia, with additional agricultural and medical campuses and academic and clinical programs across the province and beyond, we drive positive change in the communities we serve locally, nationally, and around the world. Our faculty work within a highly collaborative research community supported by major infrastructure, including Canada’s largest aquatic research facility and advanced platforms accelerating discoveries in health and the physical sciences. Researchers contribute to and benefit from a growing network of centres, institutes, and hubs driving discovery and industry partnership in areas like battery innovation and clean technologies, carbon capture and storage, additive manufacturing, AI and semiconductors, vaccine and immunotherapy development, genomics, cancer treatment, and much more.